These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4609602)

  • 1. Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).
    Cohen JL; Irwin LE; Marshall GJ; Darvey H; Bateman JR
    Cancer Chemother Rep; 1974; 58(5 Pt 1):723-31. PubMed ID: 4609602
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.
    Stolinsky DC; Pugh RP; Bateman JR
    Cancer Chemother Rep; 1975; 59(5):1031-3. PubMed ID: 1106846
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion.
    Fraile RJ; Baker LH; Buroker TR; Horwitz J; Vaitkevicius VK
    Cancer Res; 1980 Jul; 40(7):2223-8. PubMed ID: 7388790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The administration of 5-fluorouracil by mouth.
    Bruckner HW; Creasey WA
    Cancer; 1974 Jan; 33(1):14-8. PubMed ID: 4810089
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of 5-fluorouracil (NSC-19893) plasma levels in rats and man by isotope dilution-mass fragmentography.
    Finj C; Sadée W
    Cancer Chemother Rep; 1975; 59(2 Pt 1):279-86. PubMed ID: 1097091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential recovery of intestine, bone marrow, and thymus of rats with solid tumors following 5-fluorouracil administration.
    Hopkins HA; Kovacs CJ; Looney WB; Wakefield JA
    Cancer Biochem Biophys; 1976; 1(6):303-12. PubMed ID: 189899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism and pharmacology of 5-fluorouracil.
    Miller E
    J Surg Oncol; 1971; 3(3):309-15. PubMed ID: 4942414
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thymidylate synthetase activity in bone marrow cells of folic acid deflcient rats (author's transl)].
    Sakamoto S; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1973 Aug; 36(4):556-62. PubMed ID: 4799450
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetic alterations induced by 5-fluorouracil in bone marrow, intestinal mucosa, and tumor.
    Myers CE; Young RC; Chabner BA
    Cancer Res; 1976 May; 36(5):1653-8. PubMed ID: 1268826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic studies of 5-fluorouracil. II. Influence of the route of administration on the dynamics of distribution in man.
    Douglass HO; Mittelman A
    Cancer; 1974 Dec; 34(6):1878-81. PubMed ID: 4373162
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic studies of 5-fluorouracil after oral and intravenous administration in man.
    Almersjö OE; Gustavsson BG; Regårdh CG; Wåhlén P
    Acta Pharmacol Toxicol (Copenh); 1980 May; 46(5):329-36. PubMed ID: 7376884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of 3H from deoxyuridine and thymidine for synthesis of DNA and tother macromolecules in various organs of the rat.
    Hopkins HA; Wakefield JA
    Biochem Pharmacol; 1977 Jan; 26(1):59-61. PubMed ID: 188427
    [No Abstract]   [Full Text] [Related]  

  • 13. Mechanism of pyrimethamine-induced megaloblastosis in human bone marrow.
    Waxman S; Herbert V
    N Engl J Med; 1969 Jun; 280(24):1316-9. PubMed ID: 5771778
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics of oral and intravenous fluorouracil in humans.
    Phillips TA; Howell A; Grieve RJ; Welling PG
    J Pharm Sci; 1980 Dec; 69(12):1428-31. PubMed ID: 7463330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of 5-fluorouracil (NSC-19893) distribution in rodents with toxicity and chemotherapy in man.
    Liss RH; Chadwick M
    Cancer Chemother Rep; 1974; 58(6):777-86. PubMed ID: 4475611
    [No Abstract]   [Full Text] [Related]  

  • 16. 5-Fluorouracil: a comparative pharmacokinetic study and preliminary results of a clinical phase I study.
    Obrecht JP; Weber W; Cano JP; Crevoisier C; Alberto P; Forgo I; Heintz R; Germano GH
    Recent Results Cancer Res; 1981; 79():101-7. PubMed ID: 7302355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced gastric carcinoma with 5-fluorouracil: a randomized comparison of two routes of delivery.
    Chlebowski RT; Paroly WS; Pugh RP; Weiner JM; Bateman JR
    Cancer Treat Rep; 1979; 63(11-12):1979-81. PubMed ID: 393383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of 5-fluorouracil in plasma by GC/MS using an internal standard. Applications to pharmacokinetics.
    Cano JP; Rigault JP; Aubert C; Carcassonne Y; Seitz JF
    Bull Cancer; 1979; 66(1):67-74. PubMed ID: 420949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of 5-fluorouracil after oral and intravenous administration in cancer patients.
    Finch RE; Bending MR; Lant AF
    Br J Clin Pharmacol; 1979 Jun; 7(6):613-7. PubMed ID: 465283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered sensitivity of hematopoietic stem cells to 5-fluorouracil (NSC-19893) following endotoxin (NSC-189681), cyclophosphamide (NSC-26271), or irradiation.
    Eaves AC; Bruce WR
    Cancer Chemother Rep; 1974; 58(6):813-20. PubMed ID: 4447924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.